Weizhang Xu

1.3k total citations
28 papers, 868 citations indexed

About

Weizhang Xu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Weizhang Xu has authored 28 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Cancer Research and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Weizhang Xu's work include Epigenetics and DNA Methylation (6 papers), RNA modifications and cancer (6 papers) and Cancer-related molecular mechanisms research (6 papers). Weizhang Xu is often cited by papers focused on Epigenetics and DNA Methylation (6 papers), RNA modifications and cancer (6 papers) and Cancer-related molecular mechanisms research (6 papers). Weizhang Xu collaborates with scholars based in China, United States and France. Weizhang Xu's co-authors include Rong Yin, Siwei Wang, Lin Xu, Zhifei Ma, Wenjia Xia, Youtao Xu, Mantang Qiu, Erbao Zhang, Hongzhou Cai and Ting Xu and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Weizhang Xu

28 papers receiving 865 citations

Peers

Weizhang Xu
Comparison fields: 5 of 63
  • Molecular Biology 609
  • Cancer Research 449
  • Pulmonary and Respiratory Medicine 190
  • Oncology 120
  • Immunology 84
Replace Tomoaki Takai with:
Tomoaki Takai Japan
Zi‐Qi Zheng China
Kristýna Pivovarčíková Czechia
Wenjia Xia China
Yu Liang China
Junming Bi China
Xueni Xu China
Zhicheng He China
Tomoaki Takai Japan View profile →
Citations per field, relative to Weizhang Xu
Weizhang Xu · 1×
Citations per year, relative to Weizhang Xu
Weizhang Xu · 1×

Countries citing papers authored by Weizhang Xu

Since Specialization
Citations

This map shows the geographic impact of Weizhang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weizhang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weizhang Xu more than expected).

Fields of papers citing papers by Weizhang Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weizhang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weizhang Xu. The network helps show where Weizhang Xu may publish in the future.

Co-authorship network of co-authors of Weizhang Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Weizhang Xu. A scholar is included among the top collaborators of Weizhang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weizhang Xu. Weizhang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1 3
2 13
3 50
4 13
5 11
6 17
7 15
8 3
9 80
10 1
11 215
12 7
13 3
14 190
15 64
16 6
17 1
18 12
19 6
20 12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026